Capitol Health merger progress

Capitol Health (ASX: CAJ) is moving forward with its proposed merger with Integral Diagnostics Limited (ASX: IDX). The Australian Competition and Consumer Commission (ACCC) has given the green light, contingent on the divestment of Capitol's Melton clinic. Capitol will now seek court approval, with the merger expected to finalize on 20 December 2024.

Merger and future outlook

Capitol Health (ASX: CAJ) has received ACCC clearance to proceed with its merger with Integral Diagnostics, following the agreement to divest a clinic in Melton, Victoria. The company will now seek Federal Court approval, aiming to implement the merger on 20 December 2024. This merger aligns with both companies' strategic goals to enhance their operations and expand their capabilities within the medical imaging sector, subject to meeting all regulatory and legal conditions.

Executive commentary on merger

The ACCC's decision not to oppose the merger is a significant step forward. We are committed to completing the divestment and working with Integral Diagnostics to ensure a smooth transition.